Growing Use of Oat-Based Bioactives Supporting Avenanthramides Market Growth

The global avenanthramides market size was estimated at USD 145.1 million in 2025 and is projected to reach USD 295.0 million by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market is witnessing significant growth due to increasing demand for natural and evidence-based anti-inflammatory ingredients across the cosmetic, pharmaceutical, and nutraceutical industries. Avenanthramides, which are bioactive compounds primarily derived from oats, are gaining strong recognition for their antioxidant, anti-inflammatory, and skin-soothing properties. Growing consumer preference for clean-label, plant-based, and naturally sourced ingredients is further accelerating the adoption of avenanthramides in various health and wellness applications. In addition, the rising use of oat-derived actives in skincare formulations, dietary supplements, and therapeutic products is contributing positively to market expansion. Increasing awareness regarding preventive healthcare and demand for functional ingredients with scientifically supported health benefits are also supporting long-term market growth.

Patents and ongoing clinical advancements are playing a crucial role in supporting the growth of the avenanthramides market by validating the effectiveness and safety of these compounds for various therapeutic and cosmetic applications. Manufacturers and biotechnology companies are increasingly investing in research and development activities to improve extraction technologies, enhance product purity, and expand the application scope of avenanthramides.

Rising consumer interest in oat-derived active ingredients due to their natural origin and clinically supported anti-inflammatory benefits is further strengthening market demand. However, limited availability of high-quality raw materials and the complexity associated with extraction and purification processes continue to keep production costs relatively high. These factors contribute to higher product pricing and profit margins, which in turn encourage greater investments in specialized processing infrastructure, advanced manufacturing capabilities, and sustainable production methods.

Download a free sample copy of the Avenanthramides market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• Asia Pacific dominated the market in 2025, accounting for 43.2% of the total revenue share. The regional market growth is primarily driven by increasing consumer awareness regarding natural health ingredients, rapid expansion of the cosmetics and nutraceutical industries, and rising demand for plant-based bioactive compounds across countries such as China, Japan, South Korea, and India. Growing investments in biotechnology research, expanding healthcare infrastructure, and increasing preference for functional skincare and wellness products are also contributing significantly to regional market growth.
• By product, the synthetic segment dominated the market and accounted for the largest revenue share of 93.2% in 2025. The dominance of the synthetic segment can be attributed to its large-scale production capabilities, cost-effectiveness, consistent quality standards, and wider commercial availability compared to naturally extracted alternatives. Synthetic avenanthramides are extensively utilized across pharmaceutical and cosmetic applications where high purity, stability, and controlled formulations are required for large-scale manufacturing processes.
• By end use, the pharmaceuticals segment is expected to grow fastest with a CAGR of 9.9% from 2026 to 2033. The increasing application of avenanthramides in pharmaceutical formulations targeting inflammation-related conditions, skin disorders, oxidative stress, and chronic diseases is significantly driving segment growth. Rising investments in clinical research and increasing focus on plant-based therapeutic compounds are also contributing to the expanding adoption of avenanthramides within the pharmaceutical industry.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The avenanthramides market is led by a few specialized players focused on innovation, clinical validation, and scalable production of oat-derived bioactive compounds for diverse applications. These companies are actively investing in advanced biotechnology solutions, sustainable extraction methods, and product development initiatives to strengthen their market presence and meet the growing global demand for natural functional ingredients.

Ceapro Inc. is a biotechnology company specializing in the development and commercialization of oat-derived active ingredients, including avenanthramides. The company focuses on proprietary extraction technologies, clinical validation, and sustainable manufacturing practices to deliver high-purity bioactive ingredients for commercial applications. It supports a wide range of industries, including personal care, nutraceuticals, and pharmaceuticals, by offering research-backed and scientifically validated solutions. Ceapro’s strong emphasis on innovation, product quality, and sustainable production has positioned the company as a key participant in the global avenanthramides market.

Cosciens Biopharma Inc. is a clinical-stage biopharmaceutical company focused on advancing plant-based bioactive compounds for therapeutic and healthcare applications. The company emphasizes rigorous clinical research and scientific validation to ensure the safety, efficacy, and reliability of its bioactive ingredients, particularly for anti-inflammatory and health-related applications. Through strategic collaborations, biotechnology integration, and continuous research initiatives, Cosciens Biopharma develops innovative treatment solutions targeting inflammation, oxidative stress, and related medical conditions. Its focus on biotechnology innovation and clinical advancement supports its growing presence in the global avenanthramides market.

Key Avenanthramides Companies:

• Ceapro Inc.
• Cosciens Biopharma Inc.
• Chemicea Pharma
• Symrise AG
• Chen Lan gBio
• Henan Steeda Industrial Co., Ltd.
• BioCrick

Explore Grand View Horizon to see global and regional level statistics related to the Avenanthramides Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering